Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
NASH Drug Development: Experts Argue The Case For Noninvasive Tests As Surrogate Endpoints For Approval
Sep 22 2023
•
By
Sue Sutter
An FDA official cautioned against trying to build a surrogate on a surrogate. • Source: Shutterstock
More from Approval Standards
More from Pathways & Standards